Home - Products - Angiogenesis - CDK - CDK9 inhibitor HH1

CDK9 inhibitor HH1

CAS No. 204188-41-0

CDK9 inhibitor HH1( —— )

Catalog No. M13175 CAS No. 204188-41-0

CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	76	Get Quote
10MG	104	Get Quote
25MG	168	Get Quote
50MG	246	Get Quote
100MG	357	Get Quote
500MG	851	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CDK9 inhibitor HH1
Note

Research use only, not for human use.
Brief Description

CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
Description

CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

CDK
Recptor

CDK
Research Area

——
Indication

——

Chemical Information

CAS Number

204188-41-0
Formula Weight

261.343
Molecular Formula

C13H15N3OS
Purity

>98% (HPLC)
Solubility

——
SMILES

CC(C)NC1=NC(=C(S1)C(=O)C2=CC=CC=C2)N
Chemical Name

(4-amino-2-(isopropylamino)thiazol-5-yl)(phenyl)methanone

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Zhang H, et al. Cell. 2018 Nov 15;175(5):1244-1258.e26.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

SB1317 hydrochloride

SB1317 is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).
WHI-P180

WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
ON123300

ON123300 is a potent, multi-targeted kinase inhibitor with IC50 of 5, 3.9, 26, 26, 9.2 and 11 nM for ARK5, CDK4, PDGFRβ, FGFR1, RET and FYN, respectively.

Sign In Join Free